Guidelines and Journal Articles
NSTC members have compiled a list of online links to recommended guidelines and journal articles related to TB.
Featured Guideline
Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection — United States, 2010 MMWR 2010; 59 (RR-5): 1-25
Featured Articles
Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection MMWR 2011; 60:1650-1653
Trends in Tuberculosis — United States, 2010 MMWR March 25, 2011; 60 (No.11): 333-337
Boehme CC et al. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance NEJM 2010 (9/9); 363:1005
Other Guidelines
Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis MMWR 2009; 58 (01): 7-10
Treatment of Tuberculosis MMWR 2003; 52 (No. RR-11)
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection MMWR 2000; 49 (No. RR-6)
- Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection MMWR2003; 52 (No. 31)
- Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations — United States, 2001 MMWR2001; 50 (No. 34) (August 31, 2001)
- Fatal and Severe Hepatitis Associated With Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection — New York and Georgia, 2000MMWR 2001; 50 (No. 15) (April 20, 2001)
- Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis InfectionMMWR 2003; 52 (No. 31)
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
Notice to Readers: Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis MMWR 2008; 57 (No. 04, 98)
Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC MMWR 2005; 54 (No. RR-15, 1-37)
Plan to Combat Extensively Drug-Resistant Tuberculosis MMWR 2009; 58 (RR-03)
Controlling Tuberculosis in the United States Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America MMWR 2005; 54 (No. RR-12)
Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005 MMWR 2005; 54 (No. RR-17, 1-141)
- Additional FAQ’s for Clarification of Recommendations in the Guidelines
- Appendix B. Tuberculosis (TB) Risk Assessment Worksheet
Diagnostic Standards / Classification of TB in Adults and Children Am J Respir Crit Care Med 2000: 161
Report of Expert Consultations on Rapid Molecular Testing to Detect Drug-Resistant Tuberculosis in the United States CDC Web site, 2010
Other Articles
The Lancet Series on Tuberculosis The Lancet Volume 375, Issue 9728, May 19, 2010
Hurtley S, Ash C, Roberts, L. Tuberculosis and Malaria: Landscapes of Infection Science 14 May 2010: 841
David E. Griffith, et al. Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases Am J Respir Crit Care Med Feb 2007; 175: 367-416
Pediatric Tuberculosis Collaborative Group. Targeted Tuberculin Skin Testing and Treatment of Latent Tuberculosis Infection in Children and Adolescents Pediatrics Oct 2004; 114:1175-1201
